Mary L. Schapiro's most recent trade in Morgan Stanley was a trade of 2,155 Common Stock done . Disclosure was reported to the exchange on June 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley | Mary L. Schapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2025 | 2,155 | 39,196 (0%) | 0% | 0 | Common Stock | |
| Morgan Stanley | Mary L. Schapiro | Director | Grant, award, or other acquisition of securities at price $ 127.78 per share. | 01 Jun 2025 | 450 | 39,646 (0%) | 0% | 127.8 | 57,500 | Common Stock |
| Morgan Stanley | L. Mary Schapiro | Director | Grant, award, or other acquisition of securities at price $ 132.28 per share. | 01 Dec 2024 | 378 | 36,581 (0%) | 0% | 132.3 | 50,000 | Common Stock |
| CVS Health | Mary L. Schapiro | Director | 21 Nov 2024 | 2,933 | 24,436 | - | - | Deferred Stock Units | ||
| Morgan Stanley | Mary L. Schapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 2,675 | 35,676 (0%) | 0% | 0 | Common Stock | |
| CVS Health | Mary L. Schapiro | Director | 16 May 2024 | 2,912 | 21,017 | - | - | Share Credits | ||
| CVS Health | Mary L. Schapiro | Director | 15 Nov 2023 | 1,817 | 17,734 | - | - | Share Credits | ||
| Morgan Stanley | Mary L. Schapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,167 | 31,257 (0%) | 0% | 0 | Common Stock | |
| Morgan Stanley | Mary L. Schapiro | Director | Grant, award, or other acquisition of securities at price $ 82.10 per share. | 01 Jun 2023 | 609 | 31,866 (0%) | 0% | 82.1 | 50,000 | Common Stock |
| CVS Health | Mary L. Schapiro | Director | 18 May 2023 | 1,329 | 15,534 | - | - | Share Credits | ||
| Morgan Stanley | Mary L. Schapiro | Director | Grant, award, or other acquisition of securities at price $ 92.95 per share. | 01 Dec 2022 | 511 | 27,668 (0%) | 0% | 93.0 | 47,500 | Common Stock |
| CVS Health | Mary L. Schapiro | Director | 17 Nov 2022 | 1,764 | 14,107 | - | - | Share Credits | ||
| Morgan Stanley | Mary L. Schapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 2,944 | 26,754 (0%) | 0% | 0 | Common Stock | |
| CVS Health | Mary L. Schapiro | Director | 11 May 2022 | 1,709 | 12,142 | - | - | Share Credits | ||
| CVS Health | Mary L. Schapiro | Director | 17 Nov 2021 | 1,253 | 14,638 | - | - | Share Credits | ||
| CVS Health | Mary L. Schapiro | Director | 17 Nov 2021 | 417 | 7,585 (0%) | 0% | 92.7 | 38,668 | Common Stock | |
| Morgan Stanley | Mary L. Schapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 2,702 | 23,218 (0%) | 0% | 0 | Common Stock | |
| CVS Health | Mary L. Schapiro | Director | 13 May 2021 | 1,379 | 13,230 | - | - | Share Credits | ||
| CVS Health | Mary L. Schapiro | Director | 13 May 2021 | 459 | 7,168 (0%) | 0% | 84.3 | 38,680 | Common Stock | |
| CVS Health | Mary L. Schapiro | Director | 18 Nov 2020 | 2,336 | 6,709 (0%) | 0% | 66.4 | 154,994 | Common Stock |